Orthobiologics

curasan is launching Spinevisc® hyaluronic acid for the treatment of facet syndrome....

Cellular Biomedicine's drug application for ReJoin® therapy for knee osteoarthritis was accepted for a Phase II clinical trial in China. ...

Preclinical study results demonstrated that intradiscal injection of Discogenic Cells, the active ingredient in DiscGenics' IDCT allogeneic cell therapy, may be a viable treatment...

Medtronic commenced site recruitment in a prospective, randomized pivotal clinical trial on the use of Infuse Bone Graft in TLIF....

Kuros Biosciences commenced full launch of MagnetOs bone graft substitute granules....

Hensler Surgical Technologies' Hensler Bone Press is now available in an orthopedic edition for two new applications....

TheraCell is launching TheraFuze DBF® Fiber Anchors, reportedly the world's first demineralized fiber bone anchor....

Anika Therapeutics commenced initial U.S. launch of TACTOSET injectable HA-enhanced therapy to treat bone voids and other bone defects of the skeletal system....

Royal Biologics commenced U.S. commercial launch of Maxx Ultra Cord, a maximum natural thickness allograft derived from umbilical cord....

TheraCell announced the delivery of over 12,000 of its licensed novel demineralized bone fiber products, primarily for use in spinal fusions....